ibet

学术报告 - Epigenetics and Epigenomics in Cancers

报告问题:    Epigenetics and Epigenomics in Cancers  
 
报告人:      Fran ?ois Fuks,  Ph.D.
              Professor of ULB, Faculty of Medicine.
              Director of the Laboratory of Cancer Epigenetics
              Director of the ULB Cancer Research Cancer (U-CRC)  
          Faculty of Medicine, Free University of Brussels, Belgium.       
    
主持人:    杨运桂 研究员
 
时间:      2016年10月24日 (星期一)上午 10:00-11:30   
 
所在:      ibet一层报告厅 
 
报告摘要:
    Since chemical modifications of DNA or histones are reversible processes, there is potentially a huge benefit in modulating such modifications for the treatment of human cancers using pharmacological drugs. To achieve such anti-cancer therapy, it is essential to decipher the molecular mechanisms underlying epigenetic and epigenomic perturbations in tumours. We will present our recent efforts, using our epigenomic plateform EPICS (www.epics.ulb.be), to better understand and map epigenetic alterations in cancers, including DNA methylation and hydroxymethylation.We will also discuss about our very recent work on an emerging realm of biological regulation, termed RNA epigenetics. We will present our ongoing attempts to decipher the roles of a novel RNA modification: RNA hydroxymethylation.
 
接待加入!
附件下载:
【网站地图】【sitemap】